Download PDF
Thromb Haemost 1989; 61(03): 532-534
DOI: 10.1055/s-0038-1646630
International Committee Communications
Schattauer GmbH Stuttgart

Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor Concentrates

Pier Mannuccio Mannucci
On behalf of the factor VIII and IX Subcommittee, Scientific and Standardization Committee of the International Society for Thrombosis and Hemostasis
,
Massimo Colombo
On behalf of the factor VIII and IX Subcommittee, Scientific and Standardization Committee of the International Society for Thrombosis and Hemostasis
› Author Affiliations
Further Information

Publication History

Received 23 February 1989

Accepted 03 March 1989

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Schimpf K, Mannucci PM, Kreutz W, Brackmann HH, Auerswald G, Ciavarella N, Mosseler J, De Rosa V, Kraus B, Brueckmann CH, Mancuso G, Mittler U, Haschke F, Morfini M. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion. N Engl J Med 1987; 316: 918-922
    CrossrefPubMedGoogle Scholar
  • 2 Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A, non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J 1983; 287: 1754-1757
    CrossrefPubMedGoogle Scholar
  • 3 Kemoff PB A, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985; 60: 469-479
    CrossrefPubMedGoogle Scholar
  • 4 Fletcher M, Smith JK, Rizza CR. Absence of non-A, non-B hepatitis in patients receiving transfusion of severely heat-treated factor VIII concentrate. Ric Clin Lab 1986; 16 (01) 243
    PubMedGoogle Scholar
  • 5 Collins JD, Bassendine MF, Codd AA, Collins A, Femer RE, James OF W. Prospective study of post-transfusion hepatitis after cardiac surgery in a British Centre. Br Med J 1983; 287: 1422-1424
    CrossrefPubMedGoogle Scholar
  • 6 Aach RD, Lander JJ, Scherman LA, Miller WV, Kahn RA, Gitnick GL, Hollinger FB, Werch J, Szmuness W, Stevens CE, Kellner A, Weiner JM, Mosley JW. Transfusion transmitted vimses: interim analysis of hepatitis among transfused and non-transfused patients. In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 383-396
    Google Scholar
  • 7 Alter H, Purcell RH, Feinstone SM, Holland PV, Morrow AG. Non-A, non-B hepatitis: a review and interim report of an ongoing prospective study. In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 359-369
    Google Scholar
  • 8 Seeff LB, Wright EC, Zimmerman HJ, Hoofnagle JH, Dietz AA, Felsher BF, Garcia-Pout PH, Gerety RJ, Greenlee HB, Kieman T, Leevy CM, Nath N, Schiff ER, Schwartz C, Tabor E, Tamburro C, Vlaticevic Z, Zemel R, Zimmon DS. Post-transfusion hepatitis 1973-1975. A Veterans Administration Cooperative Study In: Viral Hepatitis. Vyias GN, Cohen SN, Schmid R. (eds) Franklin Institute Press; Philadelphia: 1978. pp 383-396
    Google Scholar
  • 9 Colombo M, Mannucci PM, Camelli V, Savidge GF, Gazengel C, Schinipf K. Non-A, non-B hepatitis transmitted by heat-treated factor VIII concentrates. Lancet 1985; 2: 1-6
    PubMedGoogle Scholar
  • 10 Preston FE, Hay CR M, Dewar MS, Greaves M, Triger DR. NonA, non-B hepatitis and heat treated factor VIII concentrates. Lancet 1985; 2: 213
    PubMedGoogle Scholar
  • 11 Mannucci PM, Colombo M, Rodeghiero F. Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroform. Lancet 1985; 2: 1013
    PubMedGoogle Scholar
  • 12 Kemoff PB A, Miller EJ, Savidge GF, Machin SJ, Dewar MS, Preston FE. Reduced risk of non-A, non-B hepatitis after first exposure to “wet heated” factor VIII concentrate. Br J Haematol 1987; 67: 207-211
    CrossrefPubMedGoogle Scholar
  • 13 Camelli V, Gomperts ED, Friedman A, Aledort LM, Hilgartner M, Dietrich S, Fedor EJ. Assessment for evidence of non-A, non-B hepatitis in patients given n-heptane suspended heat-treated clotting factor concentrates. Thromb Res 1987; 46: 827-834
    CrossrefPubMedGoogle Scholar
  • 14 Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right. JAMA 1983; 249: 1743-1745
    CrossrefPubMedGoogle Scholar
  • 15 Sugg U, Erhardt S, Morgenroth T, Flehmig B. Is the use of the term “Posttransfusion hepatitis type B” in its conventional sense still justifiable. Vox Sang 1983; 44: 305-311
    CrossrefPubMedGoogle Scholar
  • 16 Koziol DE, Holland PV, Ailing DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H, Alter HJ. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488-495
    CrossrefPubMedGoogle Scholar
  • 17 Colombo M, Zanuso F, Rebulla P, Giovanetti AM, Sirchia G. Increasing the use of predeposited autologous blood for transfusion. N Engl J Med 1978; 317: 570
    PubMedGoogle Scholar